WOCKHARDT
|
The Current P/B Ratio of WOCKHARDT is 5.38.
| Share Price | ₹1,437.0 | Dec 24,2025 |
| Market Cap | ₹23,350.4 Cr | |
| Book Value | ₹4,341.0 Cr | Mar2025 - Consolidated Results |
| Price/Book | 5.38x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of WOCKHARDT
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹23,350.4 Cr] as on Dec 24,2025
(/) Book Value [ ₹4,341.0 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 5.38x ]
Thus, for WOCKHARDT , the investors are currently willing to pay '5.38 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of WOCKHARDT !
The chart below summarizes the trend in P/B Ratio of WOCKHARDT over the last five years.
Historical PB (Price/Book ) ratio chart of WOCKHARDT
PB Ratio Performance Analysis for WOCKHARDT
- WOCKHARDT 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.20x.
- WOCKHARDT 's operated at median p/b ratio of 1.36x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WOCKHARDT 's p/b ratio peaked in Mar2025 at 5.31x.
- WOCKHARDT 's p/b ratio hit its five-year low in Mar2023 of 0.66x.
How does WOCKHARDT 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| WOCKHARDT | 4,341.00 | 5.38 | 23,350.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.77 | 416,884.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 11.52 | 172,442.0 |
| CIPLA LTD | 31,079.30 | 3.89 | 120,871.0 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 17.10 | 129,770.0 |
| DR REDDYS LABORATORIES LTD | 33,404.90 | 3.16 | 105,693.0 |
| MANKIND PHARMA LTD | 14,288.70 | 6.34 | 90,579.8 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 3.85 | 92,316.9 |
| LUPIN LTD | 17,119.50 | 5.63 | 96,338.9 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.16 | 70,430.9 |
| ABBOTT INDIA LTD | 4,204.27 | 14.46 | 60,807.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs WOCKHARDT 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.16x |
| Max industry PB | 17.10x |
| Median industry PB | 5.63x |
| Average industry PB | 7.21x |
You may also like the below Video Courses